antiviral activity against influenza virus (porcine H1N1 strain) to that of EGCG with improved in vitro therapeutic index.
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Influenza infections are responsible for over 3 million cases of illness and up to a half of million deaths per year. 1 Although antiviral drugs against influenza infections are available, the emergence of viral resistance to existing antiviral drugs emphasizes the demand for development of new antiviral drugs against influenza infections. In the past few years, polyphenols including quercetin (1) and its analogs, [2] [3] [4] quercetin-3--galactoside, 5 quercetin 3-rhamnoside, 6 quercetin 3--D-glucoside or isoquercetin (2) 7 ( Figure 1 ) were reported effective against influenza infections. Among them, isoquercetin (2) demonstrated a lower IC 50 value against influenza viruses and higher therapeutic index compared to that of quercetin. 7 (-)-Epigallocatechin-3-gallate (EGCG; 3) is the major polyphenol in green tea and reported to have anti-influenza virus activity 8, 9 and organic anion-transporting enhancing property. 10 Quercetin-3-gallate (4) has been reported to be effective for the treatment of inflammatory bowel disease by inhibiting Na + -K + -ATPase and/or Na + /H + exchange activities. 11 However, the synthesis and anti-influenza virus activities of 4 and its hydroxyl aryl analogs have not been reported. A hybrid of quercetin and gallate or its analogs may show improved antiviral activities. Therefore antiviral activities of derivatives of quercetin with various substitutions at the hydroxyl functions were investigated.
Herein, we report the synthesis and anti-influenza virus activities of compounds 4 -10 containing C3-dihydroxybenzoate, C3-aminohydroxybenzoates, C3'-gallate, C3'-aminopropyloxy, and C5-propyloxy functions. Among the derivatives, quercetin-3-gallate (4) which is structurally related to EGCG showed comparable antiviral activity against influenza virus porcine H1N1 as that of EGCG with improved in vitro therapeutic index. For the synthesis of C3-O-ester analogs of quercetin, a reported selective protection of the three most reactive hydroxyl functions at C7, C3', and C4' was adapted. 12 Hence, 3',4',7-tri-O-benzylquercetin (11) , derived from tribenzylation of rutin with potassium carbonate and benzyl bromide in DMF followed by removal of the C3-rutinose with hydrochloric acid and ethanol, was condensed with 3,4,5-tribenzylgallic acid (12) , 13 which was subjected to reduction with hydrazine followed by hydrogen and palladium afforded 3-aminopropyl quercetin 9 (49% overall yield). The structure of compound 32 was unequivocally determined by a single-crystal x-ray analysis ( Figure 2 ). 18 The crystal is triclinic, space group of P-1, and the R factor of 0.051. A mole of water was revealed in the crystal structure of 32. Quercetin (1) Isoquercetin (2) EGCG (3) Quercetin-3-gallate (4) 
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Supplementary data
Synthetic procedure, analysis data, and protocols for antiviral evaluation are included.
Supplementary data associate with this article can be found in the online version, at … The instrument was operated at 10,000 resolution (W mode) with dynamic range enhancement that attenuates large intensity signals. The cone voltage was 60 eV. Spectra were acquired at 16666 Hz pusher frequency covering the mass range 100 to 1200 μ and accumulating data for 2 seconds per cycle. Mass correction for exact mass determinations was made automatically with the lock mass feature in the MassLynx data system. A reference compound in an auxiliary sprayer is sampled every third cycle by toggling a "shutter" between the analysis and reference needles. The reference mass is used for a linear mass correction of the analytical cycles.
Chemicals such rutin, quercetin, and others were purchased from Fisher Scientific and Aldrich
Chemical Co.
O-Tribenzylgallic acid (12)
. 13 
2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4H-chromen-3-yl 2,5-dihydroxybenzoate (5).
A mixture of 50 mg (56 μmol) of compound 17 and 5 mg of 10% palladium/carbon in 9 ml of ethyl acetate, methanol and dichloromethane 
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